South Korea Health Ministry Seeks New Drug Reimbursement Pricing System
This article was originally published in PharmAsia News
Executive Summary
SEOUL - South Korea's health ministry has assigned a special task force to review the country's drug reimbursement pricing system, which is plagued by high costs for generic drugs and fraud linked to incentive rebates paid to doctors and hospitals
You may also be interested in...
South Korea's New Drug Pricing Policy Offers Incentives To Hospitals To Spend Less, Says Health Ministry
SEOUL - South Korea's Ministry for Health, Welfare and Family Affairs plans to unveil on Oct. 31 its new drug reimbursement pricing system, which will lower profits for higher priced generics and still reward hospitals for buying drugs at lower prices
South Korea's New Drug Pricing Policy Offers Incentives To Hospitals To Spend Less, Says Health Ministry
SEOUL - South Korea's Ministry for Health, Welfare and Family Affairs plans to unveil on Oct. 31 its new drug reimbursement pricing system, which will lower profits for higher priced generics and still reward hospitals for buying drugs at lower prices
South Korea's Pharmaceutical Output Stays Healthy
SEOUL - The outlook for Korea's pharmaceutical market remains strong with pharmaceutical production rising 9.25 percent in 2008 to KRW13.76 trillion ($12.47 billion) from 2007, Korea FDA reported